1![AACL BIOFLUX Aquaculture, Aquarium, Conservation & Legislation International Journal of the Bioflux Society The effects of COX2-inhibitors (etoricoxib and etodolac) on growth rate and mortality in Nile AACL BIOFLUX Aquaculture, Aquarium, Conservation & Legislation International Journal of the Bioflux Society The effects of COX2-inhibitors (etoricoxib and etodolac) on growth rate and mortality in Nile](https://www.pdfsearch.io/img/d8189d95eb2553a698b765ec2066d983.jpg) | Add to Reading ListSource URL: www.bioflux.com.ro- Date: 2011-12-19 12:17:14
|
---|
2![RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT ANSM - Mis à jour le : DENOMINATION DU MEDICAMENT LODINE 300 mg, comprimé pelliculé 2. COMPOSITION QUALITATIVE ET QUANTITATIVE Etodolac micronisé .............. RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT ANSM - Mis à jour le : DENOMINATION DU MEDICAMENT LODINE 300 mg, comprimé pelliculé 2. COMPOSITION QUALITATIVE ET QUANTITATIVE Etodolac micronisé ..............](https://www.pdfsearch.io/img/019c188b1d88d0c0c476a268284506da.jpg) | Add to Reading ListSource URL: www.ethypharm.fr- Date: 2015-07-15 17:54:41
|
---|
3![RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT ANSM - Mis à jour le : DENOMINATION DU MEDICAMENT LODINE 200 mg, comprimé pelliculé 2. COMPOSITION QUALITATIVE ET QUANTITATIVE Etodolac ......................... RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT ANSM - Mis à jour le : DENOMINATION DU MEDICAMENT LODINE 200 mg, comprimé pelliculé 2. COMPOSITION QUALITATIVE ET QUANTITATIVE Etodolac .........................](https://www.pdfsearch.io/img/7b1f03fc35b8247c3bae3c73ec38e504.jpg) | Add to Reading ListSource URL: www.ethypharm.fr- Date: 2015-07-15 17:54:38
|
---|
4![NRHA Forbidden Substances NRHA Forbidden Substances](https://www.pdfsearch.io/img/3d7de90b7f75255a0b1e06a01f9bd0cc.jpg) | Add to Reading ListSource URL: nrha1.comLanguage: English - Date: 2015-06-20 16:03:02
|
---|
5![Proximal Duodenal Perforation in Three Dogs Following Deracoxib Administration The purpose of this study was to describe the clinical and gross pathological findings, treatment, and outcome in three dogs receiving deraco Proximal Duodenal Perforation in Three Dogs Following Deracoxib Administration The purpose of this study was to describe the clinical and gross pathological findings, treatment, and outcome in three dogs receiving deraco](https://www.pdfsearch.io/img/893b0ba723017c660322f1b613304fa4.jpg) | Add to Reading ListSource URL: www.2ndchance.infoLanguage: English - Date: 2014-02-04 20:07:45
|
---|
6![Zubrin Rapidly-Disintegrating Tablets, NADA, Client Information Sheet, April 2004 Zubrin Rapidly-Disintegrating Tablets, NADA, Client Information Sheet, April 2004](https://www.pdfsearch.io/img/c1d1f39f2ca2ed7650dba23e425a856e.jpg) | Add to Reading ListSource URL: www.2ndchance.infoLanguage: English - Date: 2014-02-04 14:29:02
|
---|
7![READ BEFORE USING THIS PRODUCT ® READ BEFORE USING THIS PRODUCT ®](https://www.pdfsearch.io/img/69a27b2e38bcbe5796bd3d581f6be012.jpg) | Add to Reading ListSource URL: www.2ndchance.infoLanguage: English - Date: 2014-02-04 14:28:04
|
---|
8![](https://www.pdfsearch.io/img/0afb9130855a5dbf816749fee04fb81d.jpg) | Add to Reading ListSource URL: www.ema.europa.euLanguage: English - Date: 2013-07-21 06:36:37
|
---|
9![Aclin contains the active ingredient sulindac CONSUMER MEDICINE INFORMATION What is in this leaflet Aclin contains the active ingredient sulindac CONSUMER MEDICINE INFORMATION What is in this leaflet](https://www.pdfsearch.io/img/5eb0091ce485328e782803448fe08765.jpg) | Add to Reading ListSource URL: gp2u.com.auLanguage: English - Date: 2013-08-31 02:43:58
|
---|
10![Medication Guide for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (See the end of this Medication Guide for a list of prescription NSAID Medication Guide for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (See the end of this Medication Guide for a list of prescription NSAID](https://www.pdfsearch.io/img/4b43ac7d20f39bd25259cf54471d214d.jpg) | Add to Reading ListSource URL: www.entusa.comLanguage: English - Date: 2013-08-10 12:45:06
|
---|